Dimitri Lavillette

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Venues

PLoS pathogens

The EMBO journal

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

Institut Pasteur of Shanghai Chinese Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Pasteur of Shanghai Chinese Academy of Sciences Nov 01 2014

China

Professor, Principal Investigator :: Arbovirus interspecies transmission

CNRS Délégation Rhône-Auvergne May 01 2003

France

Tenure staff scientist position CR :: Institut des Sciences Biologique

Publications

Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal (2023)
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Zhi Liu, Xia Jin, Ming-Bing Xiao, Dimitri Lavillette, Jin Zhong, Ralf Bartenschlager, Gang Long
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement. The EMBO journal 42 (6) (2023)
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Yuanfei Zhu, Teng Li, Lu Lu, Junqi Zhang, Heng Yang, Jian Feng, Zhifeng Gu, Hong Tang, Lubin Jiang, Dianfan Li, Dimitri Lavillette, Xiaoming Zhang
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy. PLoS pathogens 19 (1) (2023)
Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, Thijs Kuiken, Wenyu Han, Corine H Geurts van Kessel, Yuhuan Gong, Yapei Zhao, Quan Shen, Wenming Qin, Xiao-Xu Tian, Chao Peng, Yanling Lai, Yanxing Wang, Cedric A J Hutter, Shu-Ming Kuo, Juan Bao, Caixuan Liu, Yifan Wang, Audrey S Richard, Hervé Raoul, Jiaming Lan, Markus A Seeger, Yao Cong, Barry Rockx, Gary Wong, Yu-Hai Bi, Dimitri Lavillette, Dianfan Li
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nature communications 13 (1) (2022)
Shi Yu, Xu Zheng, Bingjie Zhou, Juan Li, Mengdan Chen, Rong Deng, Gary Wong, Dimitri Lavillette, Guang-Xun Meng
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation. Proceedings of the National Academy of Sciences of the United States of America 119 (1) (2022)
Chao Zhang, Yifan Wang, Yuanfei Zhu, Caixuan Liu, Chenjian Gu, Shiqi Xu, Yalei Wang, Yu Zhou, Yanxing Wang, Wenyu Han, Xiaoyu Hong, Yong Yang, Xueyang Zhang, Tingfeng Wang, Cong Xu, Qin Hong, Shutian Wang, Qiaoyu Zhao, Weihua Qiao, Jinkai Zang, Liangliang Kong, Fangfang Wang, Hai-Kun Wang, Di Qu, Dimitri Lavillette, Hong Tang, Qiang Deng, You-Hua Xie, Yao Cong, Zhong Huang
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nature communications 12 (1) (2021)
Yong Yang, Jinkai Zang, Shiqi Xu, Xueyang Zhang, Sule Yuan, Haikun Wang, Dimitri Lavillette, Chao Zhang, Zhong Huang
Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Viruses 13 (8) (2021)
Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Martje Fentener van Vlissingen, Thijs Kuiken, Wenyu Han, Corine H Geurts van Kessel, Yuhuan Gong, Yapei Zhao, Quan Shen, Wenming Qin, Xiao-Xu Tian, Chao Peng, Yanling Lai, Yanxing Wang, Cedric A J Hutter, Shu-Ming Kuo, Juan Bao, Caixuan Liu, Yifan Wang, Audrey S Richard, Hervé Raoul, Jiaming Lan, Markus A Seeger, Yao Cong, Barry Rockx, Gary Wong, Yu-Hai Bi, Dimitri Lavillette, Dianfan Li
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nature communications 12 (1) (2021)
Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Hebang Yao, Liu Daisy Liu, Zhou Sun, Martje Fentener van Vlissingen, Thijs Kuiken, Corine H GeurtsvanKessel, Ning Zhang, Bingjie Zhou, Lu Lu, Yuhuan Gong, Wenming Qin, Moumita Mondal, Bowen Duan, Shiqi Xu, Audrey S Richard, Hervé Raoul, JianFeng Chen, Chenqi Xu, Ligang Wu, Haisheng Zhou, Zhong Huang, Xuechao Zhang, Jun Li, Yanyan Wang, Yuhai Bi, Barry Rockx, Junfang Chen, Fei-Long Meng, Dimitri Lavillette, Dianfan Li
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody. EMBO molecular medicine 13 (12) (2021)
Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, Dianfan Li
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2. PLoS pathogens 17 (3) (2021)
Fanfan Zhao, Yongfen Xu, Dimitri Lavillette, Jin Zhong, Gang Zou, Gang Long
Negligible contribution of M2634V substitution to ZIKV pathogenesis in AG6 mice revealed by a bacterial promoter activity reduced infectious clone. Scientific reports 8 (1) (2018)
Florian Douam, Floriane Fusil, Margot Enguehard, Linda Dib, Francesca Nadalin, Loïc Schwaller, Gabriela Hrebikova, Jimmy Mancip, Laurent Mailly, Roland Montserret, Qiang Ding, Carine Maisse, Emilie Carlot, Ke Xu, Els Verhoeyen, Thomas F Baumert, Alexander Ploss, Alessandra Carbone, François-Loïc Cosset, Dimitri Lavillette
A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. PLoS pathogens 14 (3) (2018)
Jiaoyu Shan, Binbin Zhao, Zhao Shan, Jia Nie, Rong Deng, Rui Xiong, Andy Tsun, Weiqi Pan, Hanzhi Zhao, Ling Chen, Ying Jin, Zhikang Qian, Kawing Lui, Rui Liang, Dan Li, Bing Sun, Dimitri Lavillette, Ke Xu, Bin Li
Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation. PLoS pathogens 13 (12) (2017)

Dimitri Lavillette.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dimitri Lavillette